Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spok HoldingsFRA:FQV 63 EBITDA Margin % is 11.31% as of Mar. 2026, which is 2% above its 10-year median of 11.11. GuruFocus rates FRA:FQV with a GF Score™ of 63/100 and a GF Value™ of €12.38 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Spok Holdings ranks better than 61.75% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Spok Holdings's EBITDA for the
three
months ended in Mar. 2026 was €3.3 Mil. Spok Holdings's Revenue for the
three
months ended in Mar. 2026 was €28.7 Mil. Therefore, Spok Holdings's EBITDA margin for the quarter that ended in Mar. 2026 was 11.31%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Spok Holdings EBITDA Margin % Related Terms
Spok Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Spok Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:FQV vs LFMD, AMWL, SY: EBITDA Margin % Comparison
For the Health Information Services subindustry, Spok Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spok Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spok Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Spok Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spok Holdings (FRA:FQV) has a EBITDA Margin % of 11.31% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Spok Holdings and its competitors. This is near median its historical median of 11.11. According to the industry distribution chart, Spok Holdings ranks #254 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 38.3%.
Is Spok Holdings' EBITDA Margin % too high?
Spok Holdings' current EBITDA Margin % of 11.31% is near median its 10-year median of 11.11. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Spok Holdings' value of 11.31% is 10.5% above this industry median. Based on the distribution chart, Spok Holdings ranks #254 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Spok Holdings has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spok Holdings' EBITDA Margin % compare to LFMD and AMWL?
According to the Healthcare Providers & Services industry distribution chart, Spok Holdings ranks #254 out of 664 companies for EBITDA Margin %. This puts Spok Holdings in the upper half of its industry. The industry median EBITDA Margin % is 10.24. Spok Holdings' value of 11.31% is 10.5% above this benchmark. While the company's 10-year median is 11.11 vs. the industry median of 10.24, Spok Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spok Holdings's current EBITDA Margin % of 11.31% is 10.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Spok Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spok Holdings's current EBITDA Margin % is 11.31%, which is near median its own 10-year median of 11.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spok Holdings stock overvalued right now?
Based on GuruFocus' analysis, Spok Holdings (FRA:FQV) is currently considered Modestly Undervalued. The stock's GF Value™ is €12.38, compared to a current price of €8.90 — trading 28.1% below its estimated fair value. The current EBITDA Margin % is 11.31%, which is near median its 10-year median of 11.11 and 10.5% above the Healthcare Providers & Services industry median of 10.24. Spok Holdings' overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Spok Holdings (FRA:FQV), the current EBITDA Margin % is 11.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spok Holdings (FRA:FQV) Overvalued in 2026?
Based on GuruFocus' analysis, Spok Holdings stock appears to be undervalued.
The current stock price of €8.90 is trading 28.1% below its estimated GF Value™ of €12.38.
GuruFocus considers Spok Holdings to be Modestly Undervalued.
Key valuation signals for FRA:FQV:
EBITDA Margin %: 11.31% (near median its 10-year median of 11.11)
GF Value™: €12.38 vs. price of €8.90 (28.1% below fair value)
Industry Position: 10.5% above the Healthcare Providers & Services median (#254 of 664)
No single metric tells the full story. See the FRA:FQV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
63GF Score
Get the complete analysis for FRA:FQV
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:FQV has been successfully added to your 
